Concepedia

Parthasarathy Chandrakesan

PC

Statistics

Publications

42

Citations

2.5K

H-Index

30

Active since

2002

Affiliations

University of Oklahoma Health Sciences Center(Current)

Coare Biotechnology (United States)

Oklahoma State University Oklahoma City

University of Oklahoma Medical Center

University of Kansas Medical Center

Parthasarathy Chandrakesan is an author at University of Oklahoma Health Sciences Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2002–2022

42

Publications

42

Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity

Kelley S. Yan, Olivier Gevaert, Grace Zheng et al. · Cell stem cell · 2017 · 370 citations · Full text

, , +12

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer

Sripathi M. Sureban, Randal May, Dongfeng Qu et al. · PLoS ONE · 2013 · 148 citations · Full text

, , +17

RETRACTED ARTICLE: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

Parthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu et al. · Molecular Cancer · 2017 · 122 citations · Full text

, , +17

XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism

Sripathi M. Sureban, Randal May, Nathaniel Weygant et al. · Cancer Letters · 2014 · 118 citations

, , +8

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1

Nathaniel Weygant, Dongfeng Qu, William L. Berry et al. · Molecular Cancer · 2014 · 116 citations · Full text

, , +17

1–5 of 42